Revenue ($USD) : $3,904,878,255 Revenue (foreign currencies) : JP¥513,331,000,000 R&D spend : not available Employees : not available Fiscal year end : 12/31/22 CEO : Yuji Hamada, president and CEO
Canon announced the establishment of its Canon Healthcare USA subsidiary in late 2022 to strengthen its presence in the American medical market. In April, it said it had kicked off clinical research in Japan with its next-generation X-ray computed tomography (CT) system. Canon’s business strategy includes boosting its competitiveness in diagnostics such as CT, magnetic resonance imaging (MRI), and diagnostic ultrasound systems — as well as medical component businesses such as X-ray tubes, X-ray detectors and key MRI components. –CN